Correlation Between Ultimovacs ASA and Bergenbio ASA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ultimovacs ASA and Bergenbio ASA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultimovacs ASA and Bergenbio ASA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultimovacs ASA and Bergenbio ASA, you can compare the effects of market volatilities on Ultimovacs ASA and Bergenbio ASA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultimovacs ASA with a short position of Bergenbio ASA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultimovacs ASA and Bergenbio ASA.

Diversification Opportunities for Ultimovacs ASA and Bergenbio ASA

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Ultimovacs and Bergenbio is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Ultimovacs ASA and Bergenbio ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bergenbio ASA and Ultimovacs ASA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultimovacs ASA are associated (or correlated) with Bergenbio ASA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bergenbio ASA has no effect on the direction of Ultimovacs ASA i.e., Ultimovacs ASA and Bergenbio ASA go up and down completely randomly.

Pair Corralation between Ultimovacs ASA and Bergenbio ASA

Assuming the 90 days trading horizon Ultimovacs ASA is expected to under-perform the Bergenbio ASA. In addition to that, Ultimovacs ASA is 1.4 times more volatile than Bergenbio ASA. It trades about -0.06 of its total potential returns per unit of risk. Bergenbio ASA is currently generating about 0.0 per unit of volatility. If you would invest  1,816  in Bergenbio ASA on September 1, 2024 and sell it today you would lose (729.00) from holding Bergenbio ASA or give up 40.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.63%
ValuesDaily Returns

Ultimovacs ASA  vs.  Bergenbio ASA

 Performance 
       Timeline  
Ultimovacs ASA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ultimovacs ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Bergenbio ASA 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bergenbio ASA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Bergenbio ASA displayed solid returns over the last few months and may actually be approaching a breakup point.

Ultimovacs ASA and Bergenbio ASA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ultimovacs ASA and Bergenbio ASA

The main advantage of trading using opposite Ultimovacs ASA and Bergenbio ASA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultimovacs ASA position performs unexpectedly, Bergenbio ASA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bergenbio ASA will offset losses from the drop in Bergenbio ASA's long position.
The idea behind Ultimovacs ASA and Bergenbio ASA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges